Oncology professionals from around the globe are at the 2018 ASCO Annual Meeting. Today’s key research highlights address the connection between microsatellite instability and Lynch syndrome, a blood test that may be used to find early lung cancer, a new targeted therapy for treating advanced breast cancer, an immunotherapy-chemotherapy combination that slows lung cancer growth, and evidence that personalized medicine helps people with cancer live longer.

Georgia Hurst, a Lynch syndrome advocate, describes from her personal experience the emotional and physical toll being diagnosed with a genetic condition that increases cancer risk can take.

Samantha Rose describes the pressure cancer survivors like her put on themselves to feel happy and optimistic after finishing treatment and how she has learned to be more patient with herself.